Perninder Dhadwar

Perninder Dhadwar is CEO of Imobisoft, a UK bespoke AI and software engineering company and co-founder of Apercus an AI enabled MLR platform that changes the way that the Pharma industry create, review, approve and monitor their medical literature assets. He brings more than 25 years of senior leadership and since joining Imobisoft in 2019 he has grown the business into an engineering organisation working with the NHS, GSK and other life science organisations. He is cited for his work on the application of digital health solutions for the management of PKU in infants (https://pubmed.ncbi.nlm.nih.gov/35683982/). The portfolio of work expands across conditions such as infant wellness, COPD, PKU and Preeclampsia. He is currently working with University Hospital Coventry & Warwickshire Trust to create algorithms which will radically overhaul the titration of medication for post heart surgery patients. He speaks on clinical AI deployment, regulated software delivery, and why the gap bet